Syphilis is a sexually transmitted infection (STI) caused by the bacterium Treponema pallidum. The infection can cause serious health problems if left untreated, including blindness, deafness, and even death. In Canada, syphilis rates have been on the rise in recent years, which is a concerning trend for public health officials.

According to the Public Health Agency of Canada, there were 4,300 reported cases of syphilis in 2019, which is a significant increase from the 3,100 cases reported in 2018. The majority of these cases (81%) were reported in men, with the highest rates of infection among men who have sex with men (MSM). However, there has also been an increase in syphilis rates among women and heterosexual men.

There are several factors that may be contributing to the rise in syphilis rates in Canada. One possible explanation is the increasing use of dating apps and online platforms for finding sexual partners. These apps have made it easier for people to connect with others and engage in casual sex, which can increase the risk of STIs.

Another factor may be a lack of awareness about the importance of safe sex practices. Many people may not be using condoms consistently or correctly, which can increase their risk of contracting syphilis and other STIs.

In addition, there may be a lack of access to testing and treatment for syphilis. Some people may not know where to go for testing, or they may be reluctant to seek care due to stigma or discrimination.To address the rising syphilis rates in Canada, public health officials are taking a multi-pronged approach. This includes increasing awareness about the importance of safe sex practices, promoting regular testing for STIs, and improving access to testing and treatment.

One important step is to ensure that healthcare providers are trained to recognize and treat syphilis. This includes providing education and resources to help providers stay up-to-date on the latest recommendations for testing and treatment.Another important strategy is to target high-risk groups, such as MSM, with prevention and testing initiatives. This includes promoting the use of condoms and regular testing, as well as offering pre-exposure prophylaxis (PrEP) for those at high risk of HIV infection.

As a provider of diagnostic tests and research services, Microbix has a role to play in addressing the rising syphilis rates in Canada. Microbix produces highly sensitive diagnostic tests like SyphCheckTM that are used to detect syphilis infections. Additionally, the company is involved in research and development efforts aimed at improving the diagnosis and treatment of syphilis. Microbix is committed to supporting efforts to reduce the spread of syphilis in Canada and globally.

Overall, the rise of syphilis rates in Canada is a concerning trend that requires action from public health officials, healthcare providers, and individuals. By increasing awareness and access to testing and treatment, we can work together to reduce the spread of this serious infection and protect the health of Canadians.